foxo4-dri peptide senolytic mouse study 2023 FOXO4-DRI: The That Targets Zombie Cells and Aging – Revolution Health & Wellness Development of a novel senolytic

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut

Examine.com reports most benefits are from animal studies

With the injections, the person should receive more of a boost

For patients receiving B12 replacement therapy for pernicious anaemia or deficiency , monitoring is typically arranged by the prescribing clinician

Injection technique: Clean the injection site with an alcohol swab and let it dry completely Pinch a fold of skin at your chosen site (abdomen, upper thigh, or upper arm work well) Insert the needle at a 45-90 degree angle into the pinched skin fold Inject slowly and steadily over several seconds Withdraw the needle and apply light pressure if needed Rotate injection sites to prevent lipohypertrophy (tissue buildup from repeated injections in the same spot)